# Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

> **NCT01587339** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 6498 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** retigabine/ezogabine
- **DRUG:** lacosamide
- **DRUG:** zonisamide
- **DRUG:** pregabalin
- **DRUG:** eslicarbazepine

## Key facts

- **NCT ID:** NCT01587339
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-07
- **Target enrollment:** 6498 (ACTUAL)
- **Last updated:** 2013-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587339, "Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01587339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*